Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

People of Pathology: Dr Bilal Ahmad – Spectrum Healthcare Partners, Concentriq Dx, and Thinking Differently About Digital Pathology

Proscia
By Author Proscia | June 12, 2023

Dr. Bilal Ahmad, Managing Director of the Spectrum Healthcare Partners (SHCP) Pathology Division, joins “People of Pathology” host Dennis Strenk to share SHCP’s digital pathology journey and the impact of Proscia’s Concentriq Dx* in seeing it through. From overcoming the shortage of pathologists to democratizing access to high-quality pathology services, he believes that digital pathology is an opportunity to fix current challenges and achieve benefits we may not even realize yet. Dr. Ahmad also speaks to why digital pathology is not a homogeneous entity and offers advice for organizations looking to go digital.

*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US under the COVID-19 enforcement policy for remote pathology devices.

Our website uses cookies. By using this site, you agree to its use of cookies.